We're running a small clinical study at Stanford, where we treat Alzheimer's patients with mild disease with a pint of plasma from young volunteers, 20-year-olds, and
Estamos realizando un pequeño estudio clínico en Stanford, donde tratamos a pacientes con principios de Alzheimer con